Roivant subsidiary stacks up positive Phase 3 news By: Triangle Business Journal via Business Journals November 10, 2017 at 12:09 PM EST Myovant Sciences has stacked up some positive Phase 3 results in support of progressing its women’s health and prostate cancer pipeline. Read More >>
